lead identification

Current approaches to drug development that rely solely on identifying statistical differences between healthy and diseased patients to pinpoint biomarkers, molecular targets, or suitable drugs often fail to provide biologically useful results. While these differences can help predict which patients are likely to have misregulation of a particular gene, receptor, or protein, the majority of …

How AI Makes Identifying Biomarkers More Accurate and Efficient Read More »